Prioritizing and stopping prescription medicines.
作者信息
Alexander G Caleb, Sayla Maliha A, Holmes Holly M, Sachs Greg A
机构信息
Robert Wood Johnson Clinical Scholars Program, MacLean Center for Clinical Medical Ethics, Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, Ill, USA.
出版信息
CMAJ. 2006 Apr 11;174(8):1083-4. doi: 10.1503/cmaj.050837.
Abstract
摘要
相似文献
1
Prioritizing and stopping prescription medicines.
CMAJ. 2006 Apr 11;174(8):1083-4. doi: 10.1503/cmaj.050837.
2
[Drug utilization decisions should be based on cost-benefit data].
Lakartidningen. 2005;102(16):1264-5; discussion 1265.
3
The prescription as final common pathway.
Int J Technol Assess Health Care. 1995 Summer;11(3):384-90. doi: 10.1017/s0266462300008606.
4
The undereducated physician's therapeutic decisions.
N Engl J Med. 1983 Jun 16;308(24):1473-4. doi: 10.1056/NEJM198306163082409.
5
A study on the factors affecting the prescription of injection medicines in Iran: a policy making approach.
Glob J Health Sci. 2015 Jan 13;7(3):291-7. doi: 10.5539/gjhs.v7n3p291.
6
Benefits, risks, and costs of prescription drugs: a scientific basis for evaluating policy options.
Clin Pharmacol Ther. 1990 Aug;48(2):111-9. doi: 10.1038/clpt.1990.125.
7
Saving money on your prescription drugs.
Johns Hopkins Med Lett Health After 50. 2010 Jan;21(11):4-5.
8
Alternatives to prescriptions for the supply and administration of POMs.
Br J Community Nurs. 2009 Mar;14(3):128-31. doi: 10.12968/bjcn.2009.14.3.40099.
9
Can 28-day prescription prevent unintentional medication surplus with 30-day prescription?
J Opioid Manag. 2017 May/Jun;13(3):135-137. doi: 10.5055/jom.2017.0379.
10
Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS.
Appl Health Econ Health Policy. 2018 Jun;16(3):317-330. doi: 10.1007/s40258-018-0383-9.
引用本文的文献
1
An Internationally Derived Process of Healthcare Professionals' Proactive Deprescribing Steps and Constituent Activities.
Pharmacy (Basel). 2024 Sep 9;12(5):138. doi: 10.3390/pharmacy12050138.
2
Deprescription in Palliative Care.
Cureus. 2023 May 27;15(5):e39578. doi: 10.7759/cureus.39578. eCollection 2023 May.
3
Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission.
J Gen Intern Med. 2019 Oct;34(10):2029-2037. doi: 10.1007/s11606-019-05152-x. Epub 2019 Jul 25.
4
Deprescribing medications for older adults in the primary care context: A mixed studies review.
Health Sci Rep. 2018 May 10;1(7):e45. doi: 10.1002/hsr2.45. eCollection 2018 Jul.
5
[Not Available].
Can Fam Physician. 2018 May;64(5):e209-e224.
6
Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline.
Can Fam Physician. 2018 May;64(5):339-351.
7
Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium.
J Comorb. 2011 Dec 27;1:28-44. doi: 10.15256/joc.2011.1.4. eCollection 2011.
8
Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.
Br J Clin Pharmacol. 2014 Oct;78(4):738-47. doi: 10.1111/bcp.12386.
9
Reducing pill burden and helping with medication awareness to improve adherence.
Can Pharm J (Ott). 2013 Sep;146(5):262-9. doi: 10.1177/1715163513500208.
10
Patient barriers to and enablers of deprescribing: a systematic review.
Drugs Aging. 2013 Oct;30(10):793-807. doi: 10.1007/s40266-013-0106-8.
本文引用的文献
1
Reconsidering medication appropriateness for patients late in life.
Arch Intern Med. 2006 Mar 27;166(6):605-9. doi: 10.1001/archinte.166.6.605.
2
Optimising drug treatment for elderly people: the prescribing cascade.
BMJ. 1997 Oct 25;315(7115):1096-9. doi: 10.1136/bmj.315.7115.1096.
3
Understanding patients' decisions. Cognitive and emotional perspectives.
JAMA. 1993 Jul 7;270(1):72-6.
Zotero 插件